Perfil
Olaf Randerath is currently the Head-Medical Affairs at APONTIS PHARMA AG.
Prior to this, he worked as the Head-Development Projects at UCB Pharma GmbH and as the Head-Clinical Development at Schwarz Pharma Deutschland GmbH.
Cargos activos de Olaf Randerath
| Empresas | Cargo | Inicio |
|---|---|---|
| APONTIS PHARMA AG | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Olaf Randerath.
| Empresas | Cargo | Fin |
|---|---|---|
| Schwarz Pharma Deutschland GmbH | Corporate Officer/Principal | - |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| APONTIS PHARMA AG | Health Technology |
| Empresas privadas | 2 |
|---|---|
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
| Schwarz Pharma Deutschland GmbH |
- Bolsa de valores
- Insiders
- Olaf Randerath
